Clinical Trial Update: A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating domvanalimab and zimberelimab plus chemotherapy for advanced upper gastrointestinal tract adenocarcinoma with metastasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Gastrointestinal Tract Adenocarcinoma

Drugs mentioned

• Domvanalimab (domvanalimab)
• Zimberelimab (zimberelimab)

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: Advanced Upper Gastrointestinal Tract Adenocarcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING